Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
QuantumPharm, Inc. ( (HK:2228) ) just unveiled an announcement.
XtalPi Holdings Limited has announced a collaboration with Guangdong Hengjian Investment Holding Co., Ltd. to advance the ‘AI+ Robotic Automation’ technology and industry integration innovation consortium project in the Guangdong-Hong Kong-Macao Greater Bay Area. This initiative aims to establish world-leading R&D infrastructure and an industrial incubation ecosystem, facilitating digital and intelligent transformation across various industries, including pharmaceuticals, new materials, and robotics. The project is expected to drive innovation and industrial transformation, enhancing the economic and social development of the Greater Bay Area and positioning it as a hub for global innovation.
More about QuantumPharm, Inc.
XtalPi Holdings Limited, formerly known as QuantumPharm Inc., is an innovative research platform company that utilizes artificial intelligence (AI) and robotics technologies to drive advancements in life sciences and materials sciences. By integrating quantum physics, AI, cloud computing, and large-scale robotics, the company provides R&D solutions, services, and products to a wide range of global industries, including pharmaceuticals, biotechnology, renewable energy, and advanced materials. XtalPi has collaborated with over 300 global enterprises and research institutions, maintaining a leading position in AI-driven scientific commercialization.
YTD Price Performance: 14.55%
Average Trading Volume: 121,947,169
Technical Sentiment Consensus Rating: Strong Sell
See more insights into 2228 stock on TipRanks’ Stock Analysis page.
